CRISPR perturbation and Bayesian network inference map immune-disease regulatory cascades in primary CD4+ T cells
The study used CRISPR knockouts of 84 genes in primary human CD4+ T cells and a new linear latent causal Bayes (LLCB) network-inference method to estimate 211 regulatory connections. Integrating the inferred network with immune GWAS analyses identified an interconnected module in which KMT2A was inferred upstream of JAK-STAT and IL-2 signaling regulators including IRF4, STAT5A/B and IL2RA, linking an epigenetic regulator to immune-disease-associated pathways.
Technology: Linear latent causal Bayes (LLCB), a Bayesian extension of linear latent causal network inference, applied to CRISPR knockout and RNA-sequencing data
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: The study used CRISPR knockouts of 84 genes in primary human CD4+ T cells and a new linear latent causal Bayes (LLCB) network-inference method to estimate 211 regulatory connections.
- Still unknown: The study perturbed 84 selected genes in primary CD4+ T cells from three donors, so this is not a complete T-cell regulatory map. LLCB “direct effects” are statistical effects adjusted for other perturbed genes and are not evidence of physical binding; effects from unperturbed genes can be attributed to modeled edges. The GWAS integration identifies pathway links, not proof that the inferred cascade causes clinical disease. A prior bioRxiv version (10.1101/2023.09.17.557749) is the same study and is not counted separately.
- AI role: LLCB inferred direct and indirect regulatory relationships from perturbation-associated expression effects across 84 targeted genes. The model-derived network and gene-program analysis, combined with immune GWAS statistics, supported the specific KMT2A-to-JAK-STAT/IL-2 regulatory finding. CRISPR perturbation supplied the experimental perturbation data; the network algorithm converted those measurements into the reported regulatory map.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11605694/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: at percentile 90 of works of the same type, year and subfield (OpenAlex work metrics, 21 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.